Although the actual financial results are probably irrelavant given the situtation, perhaps Mark and the PLC braintrust can bring the people that employ him (shareholders) up to speed on the latest plans to seek regulatory approval and commercialize RG. Maybe they can bring back the CC. Mark will likely be very jovial as he is likely still basking in the glory of his recent financial wizardry, and the comfort that he still receiving paychecks. Hard to get excited considering they have consistently failed to reach any milestones they set for themselves.
If I was the one making the decisions, I wouldn't reinstate the CCs yet. It sends a bad message to have one [or worse, no] analyst and a couple of private investors asking questions. I would probably take all projections about the US trial out of the financial report and put it out, with lots of detail and conditional timelines, as a separate release.